中药对恶性肿瘤化学治疗引起骨髓抑制的干预作用动物实验研究进展  

Advances in Animal Experimental Study of Intervention with TCM to Myelosuppression Caused by Chemotherapy of Malignant Tumor

作　　者：殷霁虹[1] 沈小珩[1] 

机构地区：[1]上海交通大学医学院附属瑞金医院,上海200025

出　　处：《上海中医药大学学报》2010年第1期78-80,共3页Academic Journal of Shanghai University of Traditional Chinese Medicine

基　　金：上海市中医临床优势专科建设基金资助项目(2008YSZK003);上海市卫生局中医药科研基金资助项目(2008L035C)

摘　　要：骨髓抑制是化学治疗恶性肿瘤引起的不良反应之一。近年来,随着骨髓抑制机制研究的不断深入以及对骨髓抑制动物模型研究的日渐成熟,中药以其疗效肯定、作用缓慢温和、持续时间较长、有利于化疗的顺利进行、毒副反应小、价格便宜等独特优势,展现出治疗骨髓抑制的美好应用前景。Myelosuppression is one of the side effects of treating malignant tumor with chemotherapy. In recent years, with the continuous development of study on mechanism and animal model of myelosuppression, the traditional Chinese medicine （TCM） shows a good prospect for treating myelosuppression with its unique advantages, such as positive curative effect, gentle and lasting action, facilitating the smooth perfornlanee of chemotherapy, tiny side effect and low cost, etc

关 键 词：中医药 恶性肿瘤 化学治疗 骨髓抑制 动物实验 

分 类 号：R285.5[医药卫生—中药学]